|
PPARalpha agonist
A PPAR modulator which activates the peroxisome proliferator-activated receptor-alpha.
carcinogenic agent
A role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
|
|
|
antilipemic drug
A substance used to treat hyperlipidemia (an excess of lipids in the blood).
|
|
|
rac-2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid
|
|
(±)-nafenopin
|
ChEBI
|
|
2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propionic acid
|
ChEBI
|
|
2-methyl-2-[p-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid
|
ChEBI
|
|
2-methyl-2-[p-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propionic acid
|
ChemIDplus
|
|
α-methyl-α-(p-1,2,3,4-tetrahydronaphth-1-ylphenoxy)propionic acid
|
ChemIDplus
|
|
C 13437 SU
|
ChemIDplus
|
|
CH 13-437
|
ChemIDplus
|
|
CH 13437
|
ChemIDplus
|
|
Ciba 13437 SU
|
ChemIDplus
|
|
D,L-nafenopin
|
ChEBI
|
|
dl-nafenopin
|
ChEBI
|
|
DL-nafenopin
|
ChEBI
|
|
SU-13437
|
ChemIDplus
|
